FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sharada Katkuri

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Physiology

Genes & Molecular Sequences

APC Genes

Anatomy

Co-author Network

Publications

TOP 3
F Gregory Buchanan; Vijaykumar R Holla; Sharada Katkuri; Pranathi Matta; Raymond DuBois
Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer.
Dingzhi Wang; Haibin Wang; Yong Guo; Wei Ning; Sharada Katkuri; Walter Wahli; Béatrice Desvergne; Sudhansu K Dey; Raymond DuBois
Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression.
Koga Komatsu; F Gregory Buchanan; Sharada Katkuri; Jason D Morrow; Hiroyasu Inoue; Michiro Otaka; Sumio Watanabe; Raymond DuBois
Oncogenic potential of MEK1 in rat intestinal epithelial cells is mediated via cyclooxygenase-2.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sharada Katkuri (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: F Gregory Buchanan; Vijaykumar R Holla; Sharada Katkuri; Pranathi Matta; Raymond DuBois
Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer.
Cancer research 2007;67(19):9380-8.
2006: Dingzhi Wang; Haibin Wang; Yong Guo; Wei Ning; Sharada Katkuri; Walter Wahli; Béatrice Desvergne; Sudhansu K Dey; Raymond DuBois
Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(50):19069-74.
2005: Koga Komatsu; F Gregory Buchanan; Sharada Katkuri; Jason D Morrow; Hiroyasu Inoue; Michiro Otaka; Sumio Watanabe; Raymond DuBois
Oncogenic potential of MEK1 in rat intestinal epithelial cells is mediated via cyclooxygenase-2.
Gastroenterology 2005;129(2):577-90.
2005: Michael G Backlund; Jason R Mann; Vijaykumar R Holla; F Gregory Buchanan; Hsin-Hsiung Tai; Erik S Musiek; Ginger L Milne; Sharada Katkuri; Raymond DuBois
15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer.
The Journal of biological chemistry 2005;280(5):3217-23.
2005: Vijaykumar R Holla; Dingzhi Wang; Joanne R Brown; Jason R Mann; Sharada Katkuri; Raymond DuBois
Prostaglandin E2 regulates the complement inhibitor CD55/decay-accelerating factor in colorectal cancer.
The Journal of biological chemistry 2005;280(1):476-83.
2004: Dingzhi Wang; Haibin Wang; Qiong Shi; Sharada Katkuri; Walter Walhi; Béatrice Desvergne; Sanjoy K Das; Sudhansu K Dey; Raymond DuBois
Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta.
Cancer cell 2004;6(3):285-95.
2004: Rajnish A Gupta; Dingzhi Wang; Sharada Katkuri; Haibin Wang; Sudhansu K Dey; Raymond DuBois
Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth.
Nature medicine 2004;10(3):245-7.